6H-Dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-propyl- - Names and Identifiers
6H-Dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-propyl- - Physico-chemical Properties
Molecular Formula | C19H22O2
|
Molar Mass | 282.38 |
Storage Condition | 2-8℃ |
6H-Dibenzo[b,d]pyran-1-ol, 6,6,9-trimethyl-3-propyl- - Introduction
Cannabivarol (CBV) is a minor cannabinoid in cannabis. It is converted from the acidic precursor acid cannabis compound (CBGA) in the cannabis plant under acidic conditions. The structure of CBV is very similar to other cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC), but it has a hydroxyl functional group in its molecular structure.
The pharmacological activity of CBV is still under study, but some potential pharmacological effects have been shown in some experiments. It has been reported that CBV has antibacterial, anti-inflammatory, antioxidant and antiepileptic activities. It also shows antiplatelet activity and may have some effect on thrombosis.
At present, the application of CBV is still in the research and exploration stage, and no clear medical use has been found. Because of the low concentration of CBV in the cannabis plant, it has been relatively poorly studied.
Regarding the preparation method of CBV, in general, it can be obtained by extracting the cannabis plant and subsequently purifying it using chromatographic techniques. However, please note that due to the low concentration of CBV and less current research, its commercial production method may not be mature.
As far as we know, CBV is relatively safe for most people, but further research is needed to confirm its safety and correct dosage. For those who do not have relevant research and evaluation, the use of CBV or the use of any unapproved cannabis products should be avoided.
Last Update:2024-04-09 21:54:55